- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06197464
FLOAT Through Anxiety: Virtual Reality Application's Efficacy as a Tool to Distract From Negative Emotions and Thoughts
April 16, 2024 updated by: Yael Enav, University of Haifa
FLOAT Through Anxiety: Examining the Efficacy and Safety of the Virtual Reality Application "Float" as a Tool to Distract From Negative Emotions and Thoughts in People With High Levels of Anxiety and Stress
The goal of this clinical trial is to examine the effectiveness and safety of the VR FLOAT application as a tool to reduce negative thoughts and feelings and anxiety symptoms in students with high levels of stress and anxiety. The main questions it aims to answer are:
- Will subjects with high levels of anxiety who will use the FLOAT application experience a more significant relief in feelings of anxiety compared to subjects in the control group?
- Will subjects who are used to using technology find greater comfort in using VR compared to subjects who are not used to it?
- What is the degree of satisfaction with the use of VR and are there any reports of side effects?Participants will [describe the main tasks participants will be asked to do, treatments they'll be given and use bullets Researchers will compare control group to see The comparison between using FLOAT as a regulation strategy after psychoeducation on emotional regulation and cognitive-behavioral use of a regulation strategy after the same psychoeducation
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
62
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Haifa, Israel
- University of Haifa
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- 'moderate' or 'severe' levels of stress and/or anxiety according to the DASS-21 questionnaire
- student
Exclusion Criteria:
- under the age of 18
- diagnoses of schizophrenia or bipolar disorder, including past or present psychotic conditions
- suicidality
- pregnant women
- do not speak or read Hebrew fluently
- a diagnosis of epilepsy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Sequential Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: control
psychoeducation on emotional regulation and distraction strategy + Application
|
psychoeducation on emotional regulation and distraction strategy + Application
|
|
Experimental: experimental
psychoeducation on emotional regulation and distraction strategy + Application with the FLOAT app
|
The experimenter gives the subject psychoeducation about emotional regulation and distraction strategy with the help of a conversation and a presentation.
The subject should wear the VR device, and use the FLOAT application.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
situational anxiety before session
Time Frame: a week
|
The State-Trait Anxiety Inventory (STAI) questionnaire.
range 20 to 100, with a higher score representing higher levels of anxiety
|
a week
|
|
situational anxiety after session
Time Frame: a week
|
The State-Trait Anxiety Inventory (STAI) questionnaire.
range 20 to 100, with a higher score representing higher levels of anxiety
|
a week
|
|
satisfaction with life
Time Frame: baseline
|
Satisfaction with Life Scale (SWLS).
5 to 35.
A high score represents higher life satisfaction and a lower score represents a lower life satisfaction
|
baseline
|
|
satisfaction with life
Time Frame: week 3, after intervention
|
Satisfaction with Life Scale (SWLS).
5 to 35.
A high score represents higher life satisfaction and a lower score represents a lower life satisfaction
|
week 3, after intervention
|
|
Ease of using the technology
Time Frame: week 3, after intervention
|
System Usability Scale (SUS).
scale from 0 to 100.
A score higher than 70 indicates good usability, while a score lower than 50 indicates low usability.
|
week 3, after intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The FLOAT user experience
Time Frame: week 3, after intervention
|
A semi-structured interview, will be analyzed qualitatively
|
week 3, after intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: YAEL ENAV, professor, University of Haifa
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 12, 2023
Primary Completion (Actual)
April 10, 2023
Study Completion (Actual)
January 20, 2024
Study Registration Dates
First Submitted
June 13, 2023
First Submitted That Met QC Criteria
January 8, 2024
First Posted (Actual)
January 9, 2024
Study Record Updates
Last Update Posted (Actual)
April 17, 2024
Last Update Submitted That Met QC Criteria
April 16, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- YAEL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.